세계의 마이코 플라즈마 검사 시장 2023-2027

■ 영문 제목 : Global Mycoplasma Testing Market 2023-2027

Technavio 회사가 출판한 조사자료로, 코드는 IRTNTR43492-23 입니다.■ 상품코드 : IRTNTR43492-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 7월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (주문후 24시간내)
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD2,500 ⇒환산₩3,375,000견적의뢰/주문/질문
Enterprise License (기업 열람용)USD4,000 ⇒환산₩5,400,000견적의뢰/주문/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
글로벌 마이코 플라즈마 검사 시장 2023-2027
마이코 플라즈마 검사 시장은 2022년부터 2027년까지 6억4551만 달러로 성장하며, 예측 기간 동안 12.25%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 마이코 플라즈마 검사 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진 요인, 과제, 그리고 약 25개 벤더에 대한 벤더 분석을 담고 있습니다.
현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 바이오 의약품 연구개발에 대한 관심 증가, 노인 인구 증가, 실시간 마이코 플라즈마 검사 도입 증가가 시장을 주도하고 있습니다.

Technavio사의 마이코 플라즈마 검사 시장은 다음과 같이 구분됩니다.

최종 용도별
- 제약 및 생명공학 기업
- 세포은행
- 학술 연구 기관
- CRO
- 기타

제품별
- 소모품
- 시스템

지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)

이 보고서는 향후 몇 년 동안 마이코 플라즈마 검사 시장의 성장을 촉진하는 주요 요인 중 하나로 벤더들의 전략적 제휴 증가를 꼽고 있습니다. 또한, 마이코플라즈마 폐렴의 유병률 증가와 폐렴 사망률에 대한 우려, 감염성 질환의 신속한 진단을 위한 이니셔티브의 증가는 시장의 큰 수요로 이어질 것으로 예상되고 있습니다.

이 보고서는 마이코 플라즈마 검사 시장에 대해 다음과 같은 영역을 다루고 있습니다.
- 마이코 플라즈마 검사 시장 규모
- 마이코 플라즈마 검사 시장 예측
- 마이코 플라즈마 검사 시장 산업 분석

강력한 벤더 분석은 고객이 시장 지위를 향상시키는 데 도움이 되도록 설계되었으며, 이에 따라 이 보고서에서는 Agilent Technologies Inc., ATCC, Akron Biotechnology LLC, Becton Dickinson and Co., Bio Techne Corp., Bionique Testing Laboratories Inc., Charles River Laboratories International Inc., DiaSorin SpA, Dilarus GmbH, F. Hoffmann La Roche Ltd., GeneCopoeia Inc., InvivoGen Corp., Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., PromoCell GmbH, Sartorius AG, ScienCell Research Laboratories Inc., SGS SA, 및 Thermo Fisher Scientific Inc. 등의 기업 정보를 분석하고 있습니다. 또한 마이코 플라즈마 검사 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것으로 예상되고 있습니다.

이 조사는 업계 주요 참여자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다.
■ 보고서 개요

1. 개요
2. 세계의 마이코 플라즈마 검사 시장 현황
3.세계의 마이코 플라즈마 검사 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 최종 용도별 시장 분석
7. 제품별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global mycoplasma testing market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global mycoplasma testing market 2017 – 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027
o Exhibit 34: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o 6.4 Cell banks – Market size and forecast 2022-2027
o Exhibit 38: Chart on Cell banks – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Cell banks – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Cell banks – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Cell banks – Year-over-year growth 2022-2027 (%)
o 6.5 Academic research institutes – Market size and forecast 2022-2027
o Exhibit 42: Chart on Academic research institutes – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Academic research institutes – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Academic research institutes – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Academic research institutes – Year-over-year growth 2022-2027 (%)
o 6.6 CROs – Market size and forecast 2022-2027
o Exhibit 46: Chart on CROs – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on CROs – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on CROs – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on CROs – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by End-user
o Exhibit 54: Market opportunity by End-user ($ million)
o Exhibit 55: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 56: Chart on Product – Market share 2022-2027 (%)
o Exhibit 57: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 58: Chart on Comparison by Product
o Exhibit 59: Data Table on Comparison by Product
o 7.3 Consumables – Market size and forecast 2022-2027
o Exhibit 60: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Consumables – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
o 7.4 Systems – Market size and forecast 2022-2027
o Exhibit 64: Chart on Systems – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Systems – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Systems – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Systems – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 68: Market opportunity by Product ($ million)
o Exhibit 69: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 75: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 91: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 95: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Canada – Market size and forecast 2022-2027
o Exhibit 99: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 103: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 107: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 119: Agilent Technologies Inc. – Overview
o Exhibit 120: Agilent Technologies Inc. – Business segments
o Exhibit 121: Agilent Technologies Inc. – Key offerings
o Exhibit 122: Agilent Technologies Inc. – Segment focus
o 12.4 ATCC
o Exhibit 123: ATCC – Overview
o Exhibit 124: ATCC – Product / Service
o Exhibit 125: ATCC – Key offerings
o 12.5 Akron Biotechnology LLC
o Exhibit 126: Akron Biotechnology LLC – Overview
o Exhibit 127: Akron Biotechnology LLC – Product / Service
o Exhibit 128: Akron Biotechnology LLC – Key offerings
o 12.6 Becton Dickinson and Co.
o Exhibit 129: Becton Dickinson and Co. – Overview
o Exhibit 130: Becton Dickinson and Co. – Business segments
o Exhibit 131: Becton Dickinson and Co. – Key news
o Exhibit 132: Becton Dickinson and Co. – Key offerings
o Exhibit 133: Becton Dickinson and Co. – Segment focus
o 12.7 Bio Techne Corp.
o Exhibit 134: Bio Techne Corp. – Overview
o Exhibit 135: Bio Techne Corp. – Business segments
o Exhibit 136: Bio Techne Corp. – Key news
o Exhibit 137: Bio Techne Corp. – Key offerings
o Exhibit 138: Bio Techne Corp. – Segment focus
o 12.8 Bionique Testing Laboratories Inc.
o Exhibit 139: Bionique Testing Laboratories Inc. – Overview
o Exhibit 140: Bionique Testing Laboratories Inc. – Product / Service
o Exhibit 141: Bionique Testing Laboratories Inc. – Key offerings
o 12.9 Charles River Laboratories International Inc.
o Exhibit 142: Charles River Laboratories International Inc. – Overview
o Exhibit 143: Charles River Laboratories International Inc. – Business segments
o Exhibit 144: Charles River Laboratories International Inc. – Key news
o Exhibit 145: Charles River Laboratories International Inc. – Key offerings
o Exhibit 146: Charles River Laboratories International Inc. – Segment focus
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 147: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 148: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 149: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 150: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 151: F. Hoffmann La Roche Ltd. – Segment focus
o 12.11 GeneCopoeia Inc.
o Exhibit 152: GeneCopoeia Inc. – Overview
o Exhibit 153: GeneCopoeia Inc. – Product / Service
o Exhibit 154: GeneCopoeia Inc. – Key offerings
o 12.12 InvivoGen Corp.
o Exhibit 155: InvivoGen Corp. – Overview
o Exhibit 156: InvivoGen Corp. – Product / Service
o Exhibit 157: InvivoGen Corp. – Key offerings
o 12.13 Lonza Group Ltd.
o Exhibit 158: Lonza Group Ltd. – Overview
o Exhibit 159: Lonza Group Ltd. – Business segments
o Exhibit 160: Lonza Group Ltd. – Key news
o Exhibit 161: Lonza Group Ltd. – Key offerings
o Exhibit 162: Lonza Group Ltd. – Segment focus
o 12.14 Merck KGaA
o Exhibit 163: Merck KGaA – Overview
o Exhibit 164: Merck KGaA – Business segments
o Exhibit 165: Merck KGaA – Key news
o Exhibit 166: Merck KGaA – Key offerings
o Exhibit 167: Merck KGaA – Segment focus
o 12.15 Norgen Biotek Corp.
o Exhibit 168: Norgen Biotek Corp. – Overview
o Exhibit 169: Norgen Biotek Corp. – Product / Service
o Exhibit 170: Norgen Biotek Corp. – Key offerings
o 12.16 Sartorius AG
o Exhibit 171: Sartorius AG – Overview
o Exhibit 172: Sartorius AG – Business segments
o Exhibit 173: Sartorius AG – Key news
o Exhibit 174: Sartorius AG – Key offerings
o Exhibit 175: Sartorius AG – Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 176: Thermo Fisher Scientific Inc. – Overview
o Exhibit 177: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 178: Thermo Fisher Scientific Inc. – Key news
o Exhibit 179: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 180: Thermo Fisher Scientific Inc. – Segment focus
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 181: Inclusions checklist
o Exhibit 182: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 183: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 184: Research methodology
o Exhibit 185: Validation techniques employed for market sizing
o Exhibit 186: Information sources
o 13.5 List of abbreviations
o Exhibit 187: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global mycoplasma testing market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on End-user – Market share 2022-2027 (%)
Exhibits31: Data Table on End-user – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Cell banks – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Cell banks – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Cell banks – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Cell banks – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Academic research institutes – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Academic research institutes – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Academic research institutes – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Academic research institutes – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on CROs – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on CROs – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on CROs – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on CROs – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by End-user ($ million)
Exhibits55: Data Table on Market opportunity by End-user ($ million)
Exhibits56: Chart on Product – Market share 2022-2027 (%)
Exhibits57: Data Table on Product – Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Product
Exhibits59: Data Table on Comparison by Product
Exhibits60: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Consumables – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Systems – Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Systems – Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Systems – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Systems – Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Product ($ million)
Exhibits69: Data Table on Market opportunity by Product ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Agilent Technologies Inc. – Overview
Exhibits120: Agilent Technologies Inc. – Business segments
Exhibits121: Agilent Technologies Inc. – Key offerings
Exhibits122: Agilent Technologies Inc. – Segment focus
Exhibits123: ATCC – Overview
Exhibits124: ATCC – Product / Service
Exhibits125: ATCC – Key offerings
Exhibits126: Akron Biotechnology LLC – Overview
Exhibits127: Akron Biotechnology LLC – Product / Service
Exhibits128: Akron Biotechnology LLC – Key offerings
Exhibits129: Becton Dickinson and Co. – Overview
Exhibits130: Becton Dickinson and Co. – Business segments
Exhibits131: Becton Dickinson and Co. – Key news
Exhibits132: Becton Dickinson and Co. – Key offerings
Exhibits133: Becton Dickinson and Co. – Segment focus
Exhibits134: Bio Techne Corp. – Overview
Exhibits135: Bio Techne Corp. – Business segments
Exhibits136: Bio Techne Corp. – Key news
Exhibits137: Bio Techne Corp. – Key offerings
Exhibits138: Bio Techne Corp. – Segment focus
Exhibits139: Bionique Testing Laboratories Inc. – Overview
Exhibits140: Bionique Testing Laboratories Inc. – Product / Service
Exhibits141: Bionique Testing Laboratories Inc. – Key offerings
Exhibits142: Charles River Laboratories International Inc. – Overview
Exhibits143: Charles River Laboratories International Inc. – Business segments
Exhibits144: Charles River Laboratories International Inc. – Key news
Exhibits145: Charles River Laboratories International Inc. – Key offerings
Exhibits146: Charles River Laboratories International Inc. – Segment focus
Exhibits147: F. Hoffmann La Roche Ltd. – Overview
Exhibits148: F. Hoffmann La Roche Ltd. – Business segments
Exhibits149: F. Hoffmann La Roche Ltd. – Key news
Exhibits150: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits151: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits152: GeneCopoeia Inc. – Overview
Exhibits153: GeneCopoeia Inc. – Product / Service
Exhibits154: GeneCopoeia Inc. – Key offerings
Exhibits155: InvivoGen Corp. – Overview
Exhibits156: InvivoGen Corp. – Product / Service
Exhibits157: InvivoGen Corp. – Key offerings
Exhibits158: Lonza Group Ltd. – Overview
Exhibits159: Lonza Group Ltd. – Business segments
Exhibits160: Lonza Group Ltd. – Key news
Exhibits161: Lonza Group Ltd. – Key offerings
Exhibits162: Lonza Group Ltd. – Segment focus
Exhibits163: Merck KGaA – Overview
Exhibits164: Merck KGaA – Business segments
Exhibits165: Merck KGaA – Key news
Exhibits166: Merck KGaA – Key offerings
Exhibits167: Merck KGaA – Segment focus
Exhibits168: Norgen Biotek Corp. – Overview
Exhibits169: Norgen Biotek Corp. – Product / Service
Exhibits170: Norgen Biotek Corp. – Key offerings
Exhibits171: Sartorius AG – Overview
Exhibits172: Sartorius AG – Business segments
Exhibits173: Sartorius AG – Key news
Exhibits174: Sartorius AG – Key offerings
Exhibits175: Sartorius AG – Segment focus
Exhibits176: Thermo Fisher Scientific Inc. – Overview
Exhibits177: Thermo Fisher Scientific Inc. – Business segments
Exhibits178: Thermo Fisher Scientific Inc. – Key news
Exhibits179: Thermo Fisher Scientific Inc. – Key offerings
Exhibits180: Thermo Fisher Scientific Inc. – Segment focus
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations

보고서 이미지

※본 조사보고서 [세계의 마이코 플라즈마 검사 시장 2023-2027] (코드 : IRTNTR43492-23) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 마이코 플라즈마 검사 시장 2023-2027] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!